Health Care & Life Sciences » Biotechnology | Fibrocell Science Inc.

Fibrocell Science Inc. | Ownership

Companies that own Fibrocell Science Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Renaissance Technologies LLC
162,281
1.74%
138,742
0%
06/30/2018
MSD Partners LP
138,592
1.49%
0
0.01%
06/30/2018
The Vanguard Group, Inc.
123,991
1.33%
49,262
0%
06/30/2018
Heights Capital Management, Inc.
117,099
1.26%
117,099
0.01%
06/30/2018
Point72 Asset Management LP
80,000
0.86%
0
0%
06/30/2018
Creative Planning, Inc.
37,202
0.4%
14,984
0%
06/30/2018
Cambridge Investment Research Advisors, Inc.
19,566
0.21%
3
0%
06/30/2018
PanAgora Asset Management, Inc.
15,589
0.17%
0
0%
06/30/2018
Geode Capital Management LLC
12,642
0.14%
900
0%
06/30/2018
Kabarec Financial Advisors Ltd.
11,000
0.12%
11,000
0.02%
06/30/2018

About Fibrocell Science

View Profile
Address
405 Eagleview Boulevard
Exton Pennsylvania 19341
United States
Employees -
Website http://www.fibrocell.com
Updated 07/08/2019
Fibrocell Science, Inc. is an autologous cell and gene therapy company, which engages in translating personalized biologics into medical breakthroughs for diseases affecting the skin and connective tissue. Its clinical and pre-clinical programs include treatments for restrictive burn scars, vocal cord scars, and acne scars. The company was founded on September 1, 2009 and is headquartered in Exton, PA.